<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" class="infobox-header">RAD18 Gene</th></tr>
<tr><th colspan="2" class="infobox-subheader">RAD18 E3 Ubiquitin Protein Ligase</th></tr>
<tr><td class="label">Gene Symbol</td><td>RAD18</td></tr>
<tr><td class="label">Full Name</td><td>RAD18 E3 Ubiquitin Protein Ligase</td></tr>
<tr><td class="label">Chromosomal Location</td><td>9q31.1</td></tr>
<tr><td class="label">NCBI Gene ID</td><td>[56852](https://www.ncbi.nlm.nih.gov/gene/56852)</td></tr>
<tr><td class="label">OMIM</td><td>[605360](https://www.omim.org/entry/605360)</td></tr>
<tr><td class="label">Ensembl ID</td><td>[ENSG00000028203](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000028203)</td></tr>
<tr><td class="label">UniProt ID</td><td>[Q9NS91](https://www.uniprot.org/uniprotkb/Q9NS91/entry)</td></tr>
<tr><td class="label">Protein Class</td><td>E3 Ubiquitin Ligase</td></tr>
<tr><td class="label">Pathway</td><td>[DNA Damage Response](/mechanisms/dna-repair)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/glioblastoma" style="color:#ef9a9a">Glioblastoma</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">15 edges</a></td>
</tr>
</table>
</div>
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" class="infobox-header">RAD18 Gene</th></tr>
<tr><th colspan="2" class="infobox-subheader">RAD18 E3 Ubiquitin Protein Ligase</th></tr>
<tr><td class="label">Gene Symbol</td><td>RAD18</td></tr>
<tr><td class="label">Full Name</td><td>RAD18 E3 Ubiquitin Protein Ligase</td></tr>
<tr><td class="label">Chromosomal Location</td><td>9q31.1</td></tr>
<tr><td class="label">NCBI Gene ID</td><td>[56852](https://www.ncbi.nlm.nih.gov/gene/56852)</td></tr>
<tr><td class="label">OMIM</td><td>[605360](https://www.omim.org/entry/605360)</td></tr>
<tr><td class="label">Ensembl ID</td><td>[ENSG00000028203](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000028203)</td></tr>
<tr><td class="label">UniProt ID</td><td>[Q9NS91](https://www.uniprot.org/uniprotkb/Q9NS91/entry)</td></tr>
<tr><td class="label">Protein Class</td><td>E3 Ubiquitin Ligase</td></tr>
<tr><td class="label">Pathway</td><td>[DNA Damage Response](/mechanisms/dna-repair)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/glioblastoma" style="color:#ef9a9a">Glioblastoma</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">15 edges</a></td>
</tr>
</table>
</div>
RAD18 (RAD18 E3 Ubiquitin Protein Ligase) is a key DNA damage response protein that plays a critical role in maintaining genome stability through [translesion DNA synthesis](/mechanisms/translesion-dna-synthesis) (TLS). The gene encodes an E3 ubiquitin ligase that partners with [RAD6A](/genes/rad6a) and [RAD6B](/genes/rad6b) to catalyze the monoubiquitination of [PCNA](/proteins/pcna), a process essential for lesion bypass during DNA replication[@kunkel2009]. This function is particularly important in post-mitotic neurons, which cannot rely on homologous recombination for DNA repair due to their non-dividing state[@bijers2019].
The RAD18-RAD6 complex represents a fundamental mechanism by which cells tolerate DNA lesions that would otherwise block replication forks. In [neurons](/entities/neurons), where DNA damage accumulates over a lifetime due to oxidative metabolism, environmental exposures, and normal cellular processes, the proper functioning of this pathway is crucial for maintaining genomic integrity and preventing [neurodegeneration](/diseases/alzheimers-disease)[@madhav2019].
The RAD18 protein contains several key structural features that enable its function in DNA damage tolerance:
The primary function of RAD18 in translesion DNA synthesis involves:
This polymerase switch mechanism allows cells to continue DNA replication despite encountering damaged bases, preventing replication fork collapse and double-strand break formation.
Beyond translesion synthesis, RAD18 also participates in [homologous recombination](/mechanisms/homologous-repair) repair pathways. The protein has been shown to:
RAD18 interacts with and is regulated by several key DNA damage response proteins:
RAD18 expression is highest in:
In neurons, RAD18 localizes to:
RAD18 and the translesion DNA synthesis pathway have emerging roles in [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis:
DNA damage accumulation: Alzheimer's disease brains show evidence of increased DNA damage, including strand breaks, oxidized bases, and telomere attrition[@kruman2004]. The RAD18-mediated TLS pathway may be overwhelmed in neurons attempting to deal with this damage load.
Amyloid-beta toxicity: Studies suggest that amyloid-beta peptides can induce DNA damage in neurons, potentially activating RAD18-mediated repair pathways. However, chronic activation may lead to pathway exhaustion and neuronal death[@madhav2019].
Tau pathology: Hyperphosphorylated tau protein, a key component of [neurofibrillary tangles](/entities/tau-protein), has been shown to sequester DNA repair proteins, potentially compromising RAD18 function in affected neurons.
In [Parkinson's disease](/diseases/parkinsons-disease), RAD18 may play important roles:
Oxidative stress: The [substantia nigra](/brain-regions/substantia-nigra) dopaminergic neurons are particularly susceptible to oxidative damage due to dopamine metabolism and mitochondrial dysfunction. This creates high demand for DNA repair pathways including RAD18-mediated TLS.
Alpha-synuclein toxicity: [Alpha-synuclein](/proteins/alpha-synuclein) aggregation, the hallmark of Lewy bodies, may interfere with DNA repair machinery. Studies suggest that alpha-synuclein can interact with DNA repair proteins and potentially impair RAD18 function.
Mitochondrial DNA damage: While RAD18 primarily acts on nuclear DNA, there is emerging evidence for mitochondrial TLS pathways that may involve RAD18 homologs.
In [ALS](/diseases/amyotrophic-lateral-sclerosis), DNA repair deficits contribute to motor neuron degeneration:
Oxidative DNA damage: Motor neurons face high metabolic demands and are exposed to reactive oxygen species, requiring robust DNA damage tolerance mechanisms.
C9orf72 toxicity: The hexanucleotide repeat expansion in C9orf72, a common genetic cause of familial ALS, may lead to R-loop formation and increased replication stress, potentially overwhelming RAD18-mediated repair[@kathuria2018].
Ataxia-telangiectasia: While not directly involving RAD18, the ATM deficiency in this disorder highlights the critical importance of DNA repair in neuronal survival.
Xeroderma pigmentosum: Patients with XP have defects in nucleotide excision repair and show extreme neurodegeneration, underscoring how DNA repair defects lead to neuronal loss.
Mouse models lacking functional Rad18 show:
Cell culture studies have demonstrated:
The RAD18 pathway represents a potential therapeutic target for neurodegenerative diseases:
Small molecule activators: Compounds that enhance RAD18 activity or PCNA ubiquitination could improve DNA damage tolerance in neurons
Gene therapy: Viral vector delivery of RAD18 to increase expression in vulnerable neuronal populations
Combination approaches: Enhancing RAD18 function alongside other DNA repair pathways (BER, NER) may provide synergistic benefits
RAD18 expression and activity levels may serve as:
The following diagram shows the key molecular relationships involving RAD18 Gene discovered through SciDEX knowledge graph analysis: